Stifel Canada analysts adjusted their stance on Medexus Pharma (MDP:CN) (OTC: PDDPF), downgrading the stock rating from Buy to Hold and reducing the price target to Cdn$3.45 from the previous Cdn$6.00 ...

Stifel Canada cut their Q4 2024 EPS estimates for shares of Russel Metals in a research report issued on Sunday, February 2nd ...

Analysts at Stifel Canada issued their Q4 2024 earnings per share estimates for Franco-Nevada in a note issued to investors ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

Stifel Canada expressed a positive outlook on Calibre Mining Corp (TSX:CXB:CN) (OTC: CXBMF), as analyst Ingrid Rico reaffirmed a Buy rating alongside a Cdn$4.00 price target. The optimism follows ...

Stifel initiated coverage of AtkinsRealis (SNCAF) with a Buy rating and C$98 price target AtkinsRealis, formerly known as SNCLavalin, is a ...

Stifel analyst Suthan Sukumar is expanding the firm’s Canada IT services coverage, but says that the firm continues to favor CGI (GIB) as its top pick in IT services given the company’s broad ...

Stifel's Andrew Carter also lowered his price target on the stock to C$14 from C$16.50. Stifel's Andrew Carter also lowered his price target on the stock to C$14 from C$16.50. Cronos (CRON) is ...

After seeing a slight dip in advisor headcount last year, Stifel CEO Ron Kruszewski is predicting a recruiting resurgence after two years in which rising markets made it unusually expensive to ...